Last reviewed · How we verify

NCT04380259

Mindfulness-Based Trauma Recovery for Refugees (MBTR-R)

Completed Phase 1, PHASE2 Last updated 8 May 2020
What this trial tests

Phase 1, PHASE2 trial testing Mindfulness-Based Trauma Recovery for Refugees (MBTR-R) in Stress Disorders, Post-Traumatic in 158 participants. Completed in 18 May 2019.

Timeline
10 May 2018
Primary endpoint
18 May 2019
18 May 2019

Quick facts

Lead sponsorUniversity of Haifa
PhasePhase 1, PHASE2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment158
Start date10 May 2018
Primary completion18 May 2019
Estimated completion18 May 2019
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

University of Haifa

Who can join

Adults 18 to 65, any sex, with Stress Disorders, Post-Traumatic or Stress Related Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Worldwide, refugees and asylum seekers suffer at high rates from trauma- and stress-related mental health problems. The investigators thus developed Mindfulness-Based Trauma Recovery for Refugees (MBTR-R) - a 9-week, mindfulness- and compassion-based, trauma-sensitive and socio-culturally adapted, group intervention for refugees and asylum seekers. The overarching aims of the study were to, first, test whether MBTR-R is an efficacious and safe mental health intervention for traumatized refugees and asylum seekers with respect to stress- and trauma-related mental health outcomes; and, second, to test theorized mechanisms of action of MBTR-R. Accordingly, the investigators conducted a randomized waitlist-controlled trial among a community sample of female and male Eritrean asylum seekers in an urban post-displacement setting in the Middle East (Israel).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prevalence and prevention of suicidal ideation among asylum seekers in a high-risk urban post-displacement setting.
    Aizik-Reebs A, Yuval K, Beyene Kesete Y, Lurie I, et al · · 2022 · cited 5× · PMID 36245417 · DOI 10.1017/s2045796022000579

Verify or expand the search:

Other recruiting trials for Stress Disorders, Post-Traumatic

Currently open trials in the same condition.

Other University of Haifa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04380259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing